Trending News
News
News
Fish Oil-Rich Diet Could Reduce Migraines
According to a study, a diet higher in fatty fish helped migraine sufferers reduce their monthly number of headaches and pain intensity.
News
94% of Cancer Patients Respond Well to COVID-19 mRNA Vaccines
Among the 131 patients studied, 94% developed a good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, seven high-risk patients did not.
News
Molecule Extracted From Chesnut Leaf Neutralizes Drug-Resistant Bacteria
Scientists isolated a molecule, extracted from the leaves of the European chestnut tree, with the power to neutralize dangerous, drug-resistant staph bacteria. Frontiers in Pharmacology published the finding, led by scientists at Emory University.
News
Malaria Vaccine Gives Strong, Lasting Protection in Clinical Trial
Two U.S. Phase 1 clinical trials of a novel candidate malaria vaccine have found that the regimen conferred unprecedentedly high levels of durable protection when volunteers were later exposed to disease-causing malaria parasites.
News
Human Peptide Found in the Brain Blocks Parkinson’s Disease Protein
A scientific collaboration has been able to identify a human endogenous peptide which strongly and specifically attaches to the α-synuclein oligomers, thus avoiding their aggregation and blocking their neurotoxicity, two processes closely related to the neurodegenerative decline of Parkinson's disease.
News
Exploiting Viruses To Infect and Kill Cancer Cells
Researchers are working on the development of novel anticancer strategies based on oncolytic viruses, that can infect, replicate in and kill cancer cells.
News
Cell-Based Immunotherapy May Be Effective Against Melanoma
Researchers demonstrate, using mice and human cells, that a cell-based immunotherapy may be effective against melanoma.
News
mRNA COVID-19 Vaccines Generate Germinal Centers Important for Lasting Immunity
A study has found evidence that the immune response to mRNA vaccines is both strong and potentially long-lasting.
News
A Delayed Second and Third Dose of the AstraZeneca Vaccine Can Boost Immune Response to SARS-CoV-2
Research on the ChAdOx1 nCoV-19, also known as the Oxford-AstraZeneca vaccine, indicates that a long interval between first and second doses does not compromise the immune response after a late second dose, and a third dose of the vaccine continues to boost antibodies against SARS-CoV-2.
News
Edible Cholera Vaccine Made of Powdered Rice Passes Safety Trial
A new vaccine to protect against deadly cholera has been made by grinding up genetically modified grains of rice. The first human trial has shown no obvious side effects and a good immune response.
Advertisement